Insights for Safer Medicines and Smarter Traceability
At Synchrypt, we care about people’s health and well-being. Through expert insights, medicine verification updates, and supply chain innovation, we help build a safer and more transparent healthcare ecosystem for everyone.
-
Counterfeit Botox Raises Alarms Over Pharmaceutical Supply Chain Vulnerabilities in Australia
Brisbane / Global — Australian regulators have issued infringement notices to a Queensland-based individual accused of importing and advertising counterfeit […] Read More →
-
MHRA Seizes £45 Million in Illegal Medicines, Exposing Weak Links in the Pharmaceutical Supply Chain
London — Britain’s medicines regulator has seized illegal and unlicensed medicines worth nearly £45 million in 2025, disrupting major criminal […] Read More →
-
Potent Synthetic Opioid in Counterfeit Pills Exposes Supply Chain Weaknesses in Canada
Winnipeg / Global — Canadian health authorities have issued a stark warning after highly potent synthetic opioids, including metonitazene, were […] Read More →
-
India’s Drug Regulator Flags Substandard and Spurious Medicines
New Delhi — India’s drug regulator has identified 167 drug samples as Not of Standard Quality (NSQ) and seven medicines […] Read More →
-
Adeleke Urges Whistleblowing to Combat Fake Medicines in Nigeria’s Pharmaceutical Supply Chain
Lagos, Nigeria — Nigerian lawmaker Senator Adeleke has called for increased whistleblowing to help combat the growing circulation of counterfeit […] Read More →
-
FDA’s ImportShield Program Strengthens Oversight at U.S. Ports, Exposing Gaps in Pharmaceutical Supply Chains
Washington, D.C. — The U.S. Food and Drug Administration (FDA) announced that its ImportShield Program has delivered significant results in […] Read More →